Isabelle Quelven

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Aqueous Solution

Mesenchymal Stem Cells

Top Venues

Molecules (Basel, Switzerland)

British journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Laure Badier, Isabelle Quelven
Zirconium 89 and Copper 64 for ImmunoPET: From Antibody Bioconjugation and Radiolabeling to Molecular Imaging. Pharmaceutics 16 (7) (2024)
Maëlle Deleuziere, Eric Benoist, Isabelle Quelven, Emmanuel Gras, Catherine Amiens
[ 18 F]-Radiolabelled Nanoplatforms: A Critical Review of Their Intrinsic Characteristics, Radiolabelling Methods, and Purification Techniques. Molecules (Basel, Switzerland) 29 (7) (2024)
Laure Badier, Isabelle Quelven
Zirconium 89 and Copper 64 for ImmunoPET: From Antibody Bioconjugation and Radiolabeling to Molecular Imaging. Pharmaceutics 16 (7) (2024)
Maëlle Deleuziere, Eric Benoist, Isabelle Quelven, Emmanuel Gras, Catherine Amiens
[ 18 F]-Radiolabelled Nanoplatforms: A Critical Review of Their Intrinsic Characteristics, Radiolabelling Methods, and Purification Techniques. Molecules (Basel, Switzerland) 29 (7) (2024)
Laure Badier, Isabelle Quelven
Zirconium 89 and Copper 64 for ImmunoPET: From Antibody Bioconjugation and Radiolabeling to Molecular Imaging. Pharmaceutics 16 (7) (2024)
Maëlle Deleuziere, Eric Benoist, Isabelle Quelven, Emmanuel Gras, Catherine Amiens
[ 18 F]-Radiolabelled Nanoplatforms: A Critical Review of Their Intrinsic Characteristics, Radiolabelling Methods, and Purification Techniques. Molecules (Basel, Switzerland) 29 (7) (2024)
Stéphanie Durand-Panteix, Jacques Monteil, Magali Sage, Armand Garot, Marie Clavel, Amal Saidi, Julien Torgue, Michel Cogné, Isabelle Quelven
Preclinical study of 212Pb alpha-radioimmunotherapy targeting CD20 in non-Hodgkin lymphoma. British journal of cancer 125 (12) (2021)